Dendreon (DNDN): Bernstein’s Analyst Now Convinced Provenge is Not Dead
Wall Street Pit Bernstein’s uber analyst Geoffrey Porges is making a big biotech call upgrading Dendreon (NASDAQ:DNDN) to Outperform from Market Perform with a $10 target (prev. $7). - Porges now convinced Provenge is not dead; Raises his estimates significantly; Sees $1+ EPS power by 2016 yielding significant upside for the stock. The basis for his upgrade is [...] View the full post at: Dendreon (DNDN): Bernstein’s Analyst Now Convinced Provenge is Not Dead No related posts.